White Paper
EU HTA in action
How Health Technology Developers can prepare for a successful JCA
Nov 06, 2025
Download

The adoption of the Health Technology Assessment Regulation (HTAR) marks a transformative milestone in the European Union (EU) market access landscape. Health Technology Developers (HTDs) will need to adapt their approach to bringing new therapies to market while navigating important questions:

  • How to balance EU Joint Clinical Assessment (JCA) against competing global evidentiary needs?
  • How can EU HTA readiness be shaped in a way that brings organizational efficiency and benefits to other regions?
  • Who to align regulatory, market access, and JCA strategies, given potential learning from the first JCAs in 2025/2026?
  • How to envisage evolving JCA readiness as the Coordination Group will undertake a review of the regulation in 2028?

Download our recent whitepaper to get answers to these questions and understand what steps you could take now to be ready for this new process.

Related solutions

Contact Us